Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Diabetes Res Clin Pract ; 80(2): 218-23, 2008 May.
Article in English | MEDLINE | ID: mdl-18190995

ABSTRACT

We presented 23 patients with necrotizing fasciitis (NF), 15 of whom had uncontrolled diabetes mellitus (DM), for risk factors, clinical signs, laboratory findings and prognosis during the period 1998 and 2006 in Istanbul. A hospital incidence of NF was 14.2/100,000 admissions. Other risk factors were obesity in 9 and recent surgical trauma in 10 patients. The mean age of the patients with DM was higher than that of the patients with non-DM (58.6+/-12.8 vs 43.0+/-17.2 years, p=0.028). The most frequently isolated microorganisms from tissue cultures were Escherichia coli, Klebsiella pneumoniae and Group A streptococci. Of the 23 patients, 9 (39%), of whom 8 had DM, died between 2 and 29 days after admission. The mortality rate and length of hospitalization were longer in diabetic patients than in others (p=0.02 and p=0.286, respectively). The mean blood glucose levels and HbA1C were higher in non-survival group than in survival group (195.6+/-41.5 vs 133.7+/-22.1 and 10.6 vs 7.4) (p=0.04, r=0.39 and p=0.03, r=0.50, respectively). In the univariate analysis, the hospitalization time (r=0.72), white blood cell count (r=0.52) and surgical debridement count (r=0.47) were found to be prognostic risk factors. Our results showed that NF is a very serious life-threatening disorder in especially diabetic patients with bad metabolic control.


Subject(s)
Diabetes Mellitus, Type 2/complications , Fasciitis, Necrotizing/etiology , Adult , Aged , Bacterial Infections/classification , Fasciitis, Necrotizing/epidemiology , Fasciitis, Necrotizing/mortality , Humans , Incidence , Length of Stay , Middle Aged , Survival Analysis , Survivors
2.
Clin Microbiol Infect ; 12(8): 782-6, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16842574

ABSTRACT

The prevalence of enterotoxigenic Bacteroides fragilis (ETBF) was investigated in stool specimens from 73 patients with colorectal cancer and from 59 control patients. Stool specimens were cultured on Bacteroides Bile Esculin agar and B. fragilis was identified by conventional methods. After DNA extraction, the enterotoxin gene (bft) was detected by PCR in 38% of the isolates from colorectal cancer patients, compared with 12% of the isolates from the control group (p 0.009). This is the first study demonstrating an increased prevalence of ETBF in colorectal cancer patients.


Subject(s)
Bacterial Toxins/toxicity , Bacteroides fragilis/pathogenicity , Colorectal Neoplasms/etiology , Metalloendopeptidases/toxicity , Adult , Aged , Bacterial Toxins/genetics , Cadherins/physiology , Feces/microbiology , Female , Humans , Interleukin-8/genetics , Male , Metalloendopeptidases/genetics , Middle Aged
3.
Eur Surg Res ; 37(4): 216-9, 2005.
Article in English | MEDLINE | ID: mdl-16260871

ABSTRACT

BACKGROUND: Early diagnosis of mesenteric ischemia can be life saving. The aim of this study is to investigate the time-dependent diagnostic value of plasma D-dimer and other ancillary laboratory evaluations such as creatine phosphokinase, lactic dehydrogenase, aspartate aminotransferase, alanine aminotransferase, amylase, and leukocyte count in an experimental superior mesenteric arterial occlusion (SMA-O) model in rats. METHODS: Forty male Wistar-Albino rats were separated into 4 groups: 2-, 4-, 6-, and 12-hour SMA-O groups. After laparotomy, the SMA was identified and ligated for 2, 4, 6 and 12 h in the 4 respective study groups. Blood samples were taken for laboratory tests 2 h after laparotomy in the control group and at the end of the ischemic period in the study groups. RESULTS: The longer the duration of mesenteric ischemia, the higher were the serum D-dimer levels in the study groups, and statistical significance was obtained at 2 h (p = 0.021). Sensitivity, positive predictive value, negative predictive value, and accuracy of the relation were 88.8, 88.8, 100 and 90%, respectively. Leukocyte count was significantly higher than controls after 12 h. No other laboratory parameter correlated positively with the duration of mesenteric ischemia. CONCLUSION: Serum D-dimer measurements may be a valuable diagnostic parameter in the early diagnosis of mesenteric ischemia.


Subject(s)
Antifibrinolytic Agents/metabolism , Fibrin Fibrinogen Degradation Products/metabolism , Ischemia , Mesenteric Arteries/pathology , Mesenteric Vascular Occlusion/blood , Mesentery/blood supply , Animals , Early Diagnosis , Humans , Ischemia/blood , Ischemia/diagnosis , Male , Rats , Rats, Wistar , Time Factors
4.
Undersea Hyperb Med ; 30(4): 321-6, 2003.
Article in English | MEDLINE | ID: mdl-14756235

ABSTRACT

AIM: This study investigates the effects of hyperbaric oxygen (HBO2) therapy on the healing capacity of colonic anastomoses under the influence of preoperative chemotherapy. MATERIAL AND METHOD: Forty male Wistar-Albino rats were divided into four groups of 10. Colonic resection and anastomosis were performed in each group. Group I (control) received no further treatment. In group II, 5-fluorouracil was administered intraperitoneally for five consecutive days preoperatively. Group III received HBO2 therapy for seven days after the anastomosis. Group IV received HBO2 therapy following the administration of preoperative 5-fluorouracil. On the seventh postoperative day, all the rats were examined to determine the bursting pressures of the anastomosis and to take tissue sample from the anastomotic line for hydroxyproline measurement. RESULTS: Bursting pressures of the anastomosis in group IV were increased significantly compared to group II. Hydroxyproline levels were significantly increased with the use of HBO2 in rats, independent of chemotherapy administration. CONCLUSION: HBO2 therapy strengthens anastomoses created under the influence of neoadjuvant chemotherapy. This technique might have a future role in the care of colon cancer patients undergoing new multimodality cancer treatments.


Subject(s)
Antimetabolites, Antineoplastic/therapeutic use , Colon/surgery , Fluorouracil/therapeutic use , Surgical Wound Dehiscence/prevention & control , Wound Healing/physiology , Anastomosis, Surgical , Animals , Colon/chemistry , Colon/drug effects , Hydroxyproline/analysis , Male , Rats , Rats, Wistar , Rupture, Spontaneous/physiopathology , Wound Healing/drug effects
5.
Undersea Hyperb Med ; 29(4): 279-85, 2002.
Article in English | MEDLINE | ID: mdl-12797669

ABSTRACT

This study was designed to investigate therapeutic effects of hyperbaric oxygen on experimentally induced colitis in rats by assessing oxidative tissue damage, neutrophil accumulation and histological changes. Six groups of animals were used. No procedures were done in the sham group. In the vehicle group, 50% ethanol-induced colitis, and in four other groups, 2,4,6-trinitrobenzene sulphonic acid-induced colonic inflammation was achieved. In acute and chronic colitis non-treatment groups, no other procedure was done. In acute and chronic colitis hyperbaric oxygen treatment groups, rats underwent hyperbaric oxygen treatment for two or fourteen days. On the third and fifteenth days respectively tissue and blood samples were taken for microscopic and macroscopic damage assessment, myeloperoxidase activity and serum carbonyl content measurements. There was significant colonic tissue damage in non-treatment groups at 48 hours and 14 days. Hyperbaric oxygen treatment ameliorated the macroscopic damage significantly in chronic colitis. Amelioration of microscopic changes was not significant in each hyperbaric oxygen-treated group. Hyperbaric oxygen treatment significantly reduced tissue myeloperoxidase activity in acute colitis and decreased plasma carbonyl content in chronic colitis. In the present study, hyperbaric oxygen treatment significantly ameliorated trinitrobenzene sulphonic acid-induced chronic colitis in rats.


Subject(s)
Colitis/therapy , Hyperbaric Oxygenation , Analysis of Variance , Animals , Colitis/chemically induced , Colitis/metabolism , Colon/pathology , Male , Oxidation-Reduction , Peroxidase/analysis , Proteins/metabolism , Rats , Rats, Wistar , Trinitrobenzenesulfonic Acid
6.
J Laparoendosc Adv Surg Tech A ; 11(2): 69-72, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11327129

ABSTRACT

PURPOSE: To evaluate the effects of CO2 or helium insufflation on bacteremia and bacterial translocation in rats with peritonitis. MATERIALS AND METHODS: Forty male Wistar-Albino rats were divided into four groups, each containing 10 rats. The rats in the first group were injected only with E. coli into their peritoneal cavities with no further manipulation. The second group, following E. coli injection, underwent midline laparotomy without manipulation of the viscera for 1 hour. After the injection of E. coli in the third and fourth groups, CO2 and helium pneumoperitoneum, respectively, were maintained for 1 hour under 14 mm Hg pressure. At the end of the sixth hour, tissue samples were taken from the liver, spleen, lung, and mesenteric lymph nodes in order to evaluate bacterial translocation. During the study, blood samples were taken from each rat at 0, 1, 2, 4, and 6 hours to demonstrate bacteremia. RESULTS: There was a significant increase in bacteremia in the CO2 pneumoperitoneum group compared with the laparotomy-only and helium groups at 1 and 2 hours. Although all the blood samples at the fourth hour were positive for E. coli in every rat of all groups, helium was associated with a lower incidence of bacteremia at the sixth hour compared with other groups (P < 0.05). The CO2 pneumoperitoneum caused bacterial translocation to all organs from which tissue samples were taken. Although there was an insignificant decrease in translocation to the liver, spleen, and lung with helium compared with CO2 insufflation, helium did not increase bacterial translocation to the spleen compared with laparotomy alone, as did CO2 (P < 0.05). CONCLUSION: Helium might be an alternative to CO2 insufflation in patients with peritonitis if these results are confirmed by further experimental and clinical trials.


Subject(s)
Bacteremia/prevention & control , Bacterial Translocation/drug effects , Carbon Dioxide/administration & dosage , Helium/administration & dosage , Peritonitis , Pneumoperitoneum, Artificial/methods , Analysis of Variance , Animals , Disease Models, Animal , Insufflation , Male , Pneumoperitoneum, Artificial/adverse effects , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL